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Neurovascular and gliovascular interactions significantly affect endothelial phenotype. Physiologically, brain
endothelium attains several of its properties by its intimate association with neurons and astrocytes. However,
during cerebrovascular pathologies such as cerebral ischemia, the uncoupling of neurovascular and gliovascular
units can result in several phenotypical changes in brain endothelium. The role of neurovascular and gliovascular
uncoupling in modulating brain endothelial properties during cerebral ischemia is not clear. Specifically, the roles of
metabolic stresses involved in cerebral ischemia, including aglycemia, hypoxia and combined aglycemia and
hypoxia (oxygen glucose deprivation and re-oxygenation, OGDR) in modulating neurovascular and gliovascular
interactions are not known. The complex intimate interactions in neurovascular and gliovascular units are highly
difficult to recapitulate in vitro. However, in the present study, we used a 3D co-culture model of brain endothelium
with neurons and astrocytes in vitro reflecting an intimate neurovascular and gliovascular interactions in vivo. While
the cellular signaling interactions in neurovascular and gliovascular units in vivo are much more complex than the
3D co-culture models in vitro, we were still able to observe several important phenotypical changes in brain
endothelial properties by metabolically stressed neurons and astrocytes including changes in barrier, lymphocyte
adhesive properties, endothelial cell adhesion molecule expression and in vitro angiogenic potential.Background
Neurovascular and gliovascular units form the functional
units in the brain [1-4]. These units consist of a highly
intimate, organized and complex association between
neurons, astrocytes, brain endothelium, pericytes and fi-
broblasts. Neurons are at the center of the neurovascular
units and astrocytes are at the center of gliovascular
units. In the gliovascular unit, astrocytes ensheath blood
vessels at one end and at the other end communicate
with neuronal pre- and post-synaptic processes [5,6].
While electrical and biochemical synapses play a key
role in neuronal information exchange, astrocytes com-
municate through the gap junctions in their end foot
processes regulated by extracellular and intracellular
signaling [7,8]. Astrocytes also play a highly important
role in neurovascular coupling [9-11]. These units work
in a perfectly synchronized manner to regulate the* Correspondence: jalexa@lsuhsc.edu
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reproduction in any medium, provided the orcentral nervous system (CNS) biochemical and physio-
logical processes involved in cerebral blood flow, brain
energetics, blood brain barrier (BBB) properties, brain
development and in responding and adapting to alter-
ations in several systemic physiological and pathophysio-
logical alterations [1,3,8,12-15].
At a fundamental level, according to the report of
stroke progress group 2002, the neurovascular unit was
defined as “the molecular influences and cell-signaling
mechanisms that characterize the interactions between
circulating blood elements and the blood vessel wall,
extracellular matrix, glia, and neurons (together, the
neurovascular unit) during ischemic and hemorrhagic
stroke” (Report of the Stroke Progress Research Group,
2002; http://www.ninds.nih.gov) [3]. Understanding the
interactions between these neurovascular components
can define the broad spectrum of events involved in the
initiation and progression of ischemia, hemorrhage,
brain inflammation, brain edema, BBB dysfunction and
white matter changes post stroke. This fundamentalral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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actions between blood vessel wall, glia and neurons and
circulating blood elements, indicating the participation
of peripheral immune system in the function of neuro-
vascular unit. The brain is considered to be an immune
privileged organ, where BBB functions to prevent infiltra-
tion of immune cells from the blood [16-18]. However,
leukocytes were observed to be present in embryonic
and adult brain in normal physiological conditions
[16,19]. These neurovascular- and gliovascular-immune
interactions gain more importance depending on the
presence of perivascular antigen presenting cells in the
inner and outer wall of the astrocyte end feet and base-
ment membrane of endothelial cells in the perivascular
space [19]. This indicates that communication with sys-
temic immune compartment might also be a part of
neurovascular and gliovascular functions [20]. However,
the physiological significance for these interactions is
not clear.
Occlusion of blood flow to any region of the brain re-
sults in deprivation of oxygen, glucose and nutrients to
the neurovascular and gliovascular units [21-23]. This re-
sults in uncoupling of neurovascular and gliovascular units
and in severe pathological alterations in the physical and
physiological properties of these units. BBB breakdown re-
sults in exacerbation of vasogenic cerebral edema which is
one of the most life threatening complications post stroke
[24,25]. This process is greatly intensified by the produc-
tion of astrocytic matrix metalloproteinases (MMPs) and
by aquaporins in the astrocytic end foot process (3–5; 11;
13). Physical swelling of the astrocyte end feet process also
contributes to increased BBB permeability indicating glio-
vascular uncoupling [7,9].One of the most important fea-
tures in the neurovascular and gliovascular uncoupling
during cerebral ischemia is the intercellular biochemical
signaling that results in perturbations in BBB permeability
[12,26,27]. Furthermore, the disturbances in the vascular
wall of neurovascular and gliovascular units also trigger
vascular remodeling and angiogenesis which are consid-
ered to be endogenous adaptive events post-stroke [28].
Normal brain endothelium is relatively inert to sup-
port leukocyte interactions. However, ischemia results in
a phenotypical change of ‘resting’ brain endothelium to
‘reactive endothelial’ phenotype thereby supporting the
infiltration of leukocytes into the infarcted brain tissue
[29]. These subtle but highly orchestrated neurovascular
and gliovascular-immune interactions during normal
physiological conditions can therefore become reactive
and chaotic due to infiltrating immune cells in the post-
stroke brain due to BBB damage, increased permeability
and expression of endothelial cell adhesion molecules
(ECAM) that facilitates these processes [23,30,31]. Fur-
thermore, release of damage associated molecular pat-
terns (DAMP) from reactive astrocytes post ischemicepisode may also function as a chemoattractant for
leukocyte infiltration [32,33], indicating that multiple
processes in neurovascular and gliovascular units during
cerebral ischemia contribute to aggravation of ischemic
brain damage not only from ‘inside’ but also from ‘out-
side’ by the participation of systemic immune responses.
Increased cytokine/chemokine milieu due to reactive
astrogliosis and infiltrating leukocytes greatly affect neu-
rovascular and gliovascular responses and modulate out-
come of the ischemic brain damage [21].
We have previously reported that cytokines differen-
tially modulate brain endothelial and gliovascular barrier
responses [24]. Furthermore, we have also observed that
the metabolic components of cerebral ischemia (i.e. agly-
cemia, hypoxia and OGDR) have differential effects on
brain endothelial adhesion molecule expression [25].
However, considering the intimate physical and bio-
chemical interactions between the primary components
of neurovascular and gliovascular units, it is not clear
how these metabolic stresses affect neurovascular and
gliovascular units. In the current study we wanted to
understand how the metabolic disturbances can affect
neurons and astrocytes which in turn could affect the
basic characteristic properties of brain endothelium in-
cluding barrier, angiogenic potential, ECAM expression
and leukocyte interactions.
Since targeting a specific cell type as a therapeutic ap-
proach for stroke has received set back, therapies aimed
at protecting neurovascular and gliovascular uncoupling
from ischemia-reperfusion induced damage has received
more attention. In order to develop efficient transla-
tional therapies, it becomes important to understand the
basic pathophysiology of interactions between the com-
ponents of neurovascular and gliovascular units. In the
present study using 3D co-culture system with endo-
thelial cells/neurons and endothelial cells/astrocytes
representing intimate neurovascular and gliovascular
coupling, we investigated the role of metabolic stresses
in modulating neurovascular and gliovascular responses
in affecting brain endothelial barrier, angiogenesis and
leukocyte interactions via ECAM expression.Results
Brain endothelial, neurovascular and gliovascular barriers
are modulated by in vitro ischemic metabolic stresses
Brain endothelial barrier
Normal Under normal conditions brain endothelial bar-
rier showed a progressive decline from 0 h baseline time
point. Significant differences between normal, aglycemic
and OGDR challenged brain endothelial barrier were ob-
served at 4d and 5d. The barrier of normal brain endo-
thelial barrier at 4d was 64.14 ± 1.4% (Figure 1A,
Additional file 1: Figure S1A).
Figure 1 Differential effects of metabolic stresses on brain endothelial, neurovascular and gliovascular barriers. A) Brain endothelial
barrier. Significant differences were observed between normal and OGDR brain endothelial barrier at 4d. B. Neurovascular barrier. Significant
differences between aglycemic, hypoxic and OGDR treated neurovascular barrier was observed from 1d until 5d compared to untreated
neurovascular barrier. C. Gliovascular barrier. While no significant differences between untreated and hypoxic gliovascular barrier were observed,
aglycemic and OGDR gliovascular barrier was significantly different from untreated from 1d to 3d. D. Comparison of untreated brain endothelial,
neurovascular and gliovascular barriers. No significant differences between brain endothelial, neurovascular and gliovascular barriers were observed
until 2d. However, neurovascular barrier was significantly lower compared to brain endothelial barrier until 4d and gliovascular barrier was
significantly lower until 5d. E. Comparison of aglycemic brain endothelial, neurovascular and gliovascular barriers. No significant differences between
aglycemic brain endothelial and neurovascular barriers were observed. However, significant increase in aglycemic gliovascular barrier was
observed until 3d. Aglycemic gliovascular barrier was significantly lower at 4d and 5d compared to aglycemic brain endothelial barrier.
F. Comparison of Hypoxic brain endothelial, neurovascular and gliovascular barriers. While hypoxic neurovascular barrier was significantly lower than
hypoxic brain endothelial barrier from 3d, hypoxic gliovascular barrier was significantly lower from 1d until 5d. G. Comparison of OGDR brain
endothelial, neurovascular and gliovascular barriers. Both OGDR neurovascular and gliovascular barriers showed a significant increase compared to
OGDR brain endothelial barrier until 3d. However, at 4d OGDR gliovascular barrier was significantly lower compared to OGDR brain endothelial
and neurovascular barriers. Repeated measures ANOVA from 0h baseline. Values are expressed in percent baseline at 0h ± SEM. Un-paired t-test
was used to check significance between groups at the same time point. # P<0.05 is considered significantly different from respective controls at
the same time point.
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tween normal and aglycemia challenged brain endothe-
lial barrier until 3d. However, the barrier of aglycemia
challenged brain endothelial was significantly higher
compared to the normal barrier at 4d and 5d. The bar-
rier of aglycemia challenged brain endothelial at 4d was
78.74 ± 2.3% (Figure 1A, Additional file 1: Figure S1A).
Hypoxia Hypoxia challenged brain endothelial barrier
showed a progressive loss of barrier from 1d similar to
normal brain endothelial barrier. At 4d the barrier of
hypoxia challenged brain endothelial was 63.7 ± 0.9%
(Figure 1A, Additional file 1: Figure S1A).
OOGDR OGDR challenged brain endothelial cells showed
no significant difference in the barrier compared to the
normal barrier until 3d. However, OGDR brain endothelialbarrier showed significant differences from 4d and 5d.
At 4d the barrier of OGDR HBMEC3 was 85.83 ± 1.6%
(Figure 1A, Additional file 1: Figure S1A).
The rank order of barrier in this experiment was ob-
served to be N=H<A<O.
Neurovascular barrier
Normal Neurovascular co-culture showed a progressive
loss of barrier from 0 h baseline time point at normal con-
ditions. Significant differences in normal and metabolic
challenged HBMEC3/SHSY-5Y co-cultures were observed
until 5d. At 4d the normal neurovascular barrier was
49.02 ± 1.5% (Figure 1B, Additional file 1: Figure S1B).
Aglycemia The barrier of aglycemia challenged neuro-
vascular co-culture was significantly higher compared
to the normal barrier until 4d. At 4d aglycemia
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Additional file 1: Figure S1B).
Hypoxia The barrier of hypoxia challenged neurovascular
co-culture barrier was significantly lower at all-time points
compared to normal or aglycemia or OGDR. At 4d hyp-
oxia challenged neurovascular barrier was 36.13 ± 1.3%
(Figure 1B, Additional file 1: Figure S1B).
OGDR The barrier of OGDR challenged neurovascular
co-culture barrier was significantly higher compared to all
other treatment conditions. At 4d OGDR challenged neu-
rovascular barrier was 78.89 ± 5.0% (Figure 1B, Additional
file 1: Figure S1B).
The rank order of barrier in this experiment was
H<N<A<O.
Gliovascular barrier
Normal Normal gliovascular co-culture barrier showed
a progressive loss of barrier from 0 h baseline time
point. Significant differences between normal, aglycemic
and OGDR challenged gliovascular co-culture barrier
were observed until from 1d until 4d. At 4d normal glio-
vascular barrier was 13.26 ± 0.4% (Figure 1C, Additional
file 1: Figure S1C).
Aglycemia Aglycemia challenged gliovascular barrier
was significantly higher compared to normal gliovascular
barrier until 4d. At 4d aglycemia challenged gliovascular
barrier was 38.58 ± 1.6% (Figure 1C, Additional file 1:
Figure S1C).
Hypoxia Hypoxia challenged gliovascular co-culture
barrier showed progressive loss from 0 h time point,
similar to normal gliovascular co-culture barrier. At 4d
hypoxia challenged gliovascular barrier was 11.4 ± 0.2%
(Figure 1C, Additional file 1: Figure S1C).
OGDR OGDR challenged gliovascular co-culture showed
a dramatic increase in from 0 h baseline time point until
4d. At 4d OGDR challenged gliovascular barrier was
44.05 ± 5.7% (Figure 1C, Additional file 1: Figure S1C).
The rank order of barrier in this experiment was
N=H<A<O.
Comparison between vascular, neurovascular and
gliovascular barriers
Normal A progressive decline in brain endothelial, neu-
rovascular and gliovascular barriers were observed under
normal conditions. While neurovascular barrier was sig-
nificantly lower than brain endothelial barrier at 3d and
4d time points, gliovascular co-cultures showed a signifi-
cantly decreased barrier from 3d to 5d compared to brainendothelial barrier under normal conditions. The barrier
differences among these barriers were maximal at 4d.
Brain endothelial barrier at 4d was 64.14 ± 1.5%, neu-
rovascular barrier was 49.02 ± 1.5% and gliovascular
barrier was 13.26 ± 0.4% (Figure 1D, Additional file 1:
Figure S1D).
The rank order in these comparisons was HBMEC3>
HBMEC3/SHSY-5Y>HBMEC3/HFA.
Aglycemia When challenged with aglycemic stress, the
brain endothelial, neurovascular and gliovascular bar-
riers showed differential responses in a time dependent
manner. While no differences in the neurovascular bar-
rier were observed until 3d, the barrier showed signifi-
cant loss at 4d and 5d. However, the gliovascular barrier
was significantly higher than the brain endothelial and
neurovascular barriers until 2d. At 3d no significant differ-
ence was observed between any groups. However, gliovas-
cular barrier was significantly lower than brain endothelial
barrier at 4d and 5d. At 2d brain endothelial barrier was
73.4 ± 1.3%, neurovascular barrier was 73.43 ± 0.5% and
gliovascular barrier was 91.99 ± 2.5%. At 4d brain endo-
thelial barrier was 78.74 ± 2.3%, neurovascular barrier was
62.22 ± 3.8% and gliovascular barrier was 38.58 ± 1.6%
(Figure 1E, Additional file 1: Figure S1E).
While the rank order of this experiment at 2d was
HBMEC3=HBMEC3/SHSY-5Y<HBMEC3/HFA, at 4d the
rank order was HBMEC3>HBMEC3/SHSY-5Y>HBMEC3/
HFA.
Hypoxia A significant decrease in hypoxia challenged
neurovascular barrier compared to brain endothelial barrier
was observed from 2d until 5d. However, hypoxia chal-
lenged gliovascular barrier was significantly lower com-
pared to brain endothelial barrier from 1d until 5d. The
differences between hypoxia challenged brain endothelial,
neurovascular and gliovascular barriers were apparent at 3d
and 4d. Hypoxia challenged neurovascular and gliovascular
barriers were significantly lower compared to brain endo-
thelial barrier at 3d and reached maximal at 4d. At 4d brain
endothelial barrier was 63.71 ± 0.9%, neurovascular barrier
was 36.13 ± 1.3% and gliovascular barrier was 11.4 ± 0.2%
(Figure 1F, Additional file 1: Figure S1F).
The rank order of this experiment was HBMEC3>
HBMEC3/SHSY-5Y>HBMEC3/HFA.
OGDR Similar to aglycemia, OGDR challenged brain
endothelial, neurovascular and gliovascular barriers showed
differential responses in a time dependent manner. OGDR
challenged neurovascular barrier was significantly higher
than HBMEC3 until 3d, no differences were observed at 4d
and 5d. While the barrier of OGDR challenged gliovascular
barrier was significantly higher than brain endothelial barrier
until 3d, at 4d the barrier was significantly lower than brain
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cells was 74.08 ± 1.1%, neurovascular barrier was 99.03 ±
1.5% and gliovascular barrier was 180 ± 6.2%. At 4d brain
endothelial barrier was 85.83 ± 1.6%, neurovascular barrier
was 78.89 ± 5% and gliovascular barrier was 44.05 ± 5.7%
(Figure 1G, Additional file 1: Figure S1G).
The rank order at 2d was HBMEC3<HBMEC3/SHSY-
5Y<HBMEC3/HFA, and the rank order at 4d was
HBMEC3=HBMEC3/SHSY-5Y>HBMEC3/HFA.
Neuronal and astrocytic interactions modulate brain
endothelial angiogenic property during in vitro ischemic
metabolic stresses
Effect of metabolic stresses on brain endothelial angiogenic
potential
Conditioned medium from aglycemic, hypoxic and OGDR
challenged brain endothelial cells (self conditioned mediumFigure 2 Differential effects of metabolic stresses on neuronal and as
potential. A. Effect of metabolically stressed brain endothelial CM (self-condit
in number of brain endothelial vessel like structures were observed with se
endothelial cells compared to untreated brain endothelial CM. B. Effect of m
significant difference in number of vessel like structures were observed wit
neuronal CM. C. Effect of metabolically stressed astrocytic CM on brain endot
structures were observed with astrocytic aglycemic and OGDR CM compar
between astrocytic hypoxic CM and untreated astrocytic CM. D. Compariso
observed with untreated neuronal CM compared to untreated brain endot
untreated brain endothelial CM was observed. E. Comparison of aglycemic C
endothelial, neuronal and astrocytic CM. F. Comparison of hypoxic CM. A sig
neuronal and astrocytic CM compared to hypoxic brain endothelial CM. G.
astrocytes. A significant decrease in vessel like structures were observed wit
endothelial CM. One way ANOVA with Bonferroni post testing was used to
used to check statistical significance between two groups.*P<0.05 is considfrom metabolically stressed brain endothelial cells) sig-
nificantly induced in vitro brain endothelial capillary
tube formation on matrigel compared to normal condi-
tioned medium from brain endothelial cells (Figure 2A).
Effect of metabolically stressed neurons on brain
endothelial angiogenic potential
Brain endothelial cells treated with conditioned medium
from metabolically stressed neurons did not show any
significant differences between each other (Figure 2B).
Effect of metabolically stressed astrocytes on brain
endothelial angiogenic potential
Interestingly, conditioned medium from metabolically
challenged astrocytes showed differential angiogenic po-
tential in brain endothelial cells. Conditioned medium
from aglycemia and OGDR challenged astrocytes inducedtrocytic interactions in modulating brain endothelial angiogenic
ioned medium) on brain endothelial angiogenesis. Significant increase
lf-CM obtained from aglycemic, hypoxic and OGDR treated brain
etabolically stressed neuronal CM on brain endothelial angiogenesis. No
h neuronal aglycemic, hypoxic or OGDR CM compared to untreated
helial angiogenesis. Significant increase in number of vessel like
ed to untreated astrocyte CM. No significant differences were observed
n of untreated CM. A significant increase in vessel like structures were
helial CM. No differences between untreated astrocytic CM and
M. No significant differences were observed between aglycemic brain
nificant decrease in vessel like structures were observed with hypoxic
Comparison of OGDR CM from brain endothelial cells, neurons and
h OGDR neuronal and astrocytic CM compared to OGDR brain
check significance between 2 specific groups. Un-paired t-test was
ered significantly different from controls.
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tube like formation (Figure 2C).
Comparison between neuronal and astrocyte CM on brain
endothelial angiogenic potential
Normal While normal astrocytic CM did not affect
brain endothelial angiogenic potential, neuronal CM sig-
nificantly increased brain endothelial in vitro capillary
tube formation compared to normal brain endothelial
CM (Figure 2D).
Aglycemia Neither aglycemia challenged neuronal CM
nor astrocytic CM affected brain endothelial angiogenic
potential in vitro compared to aglycemia challenged
brain endothelial CM (Figure 2E).
Hypoxia While brain endothelial cells treated with hyp-
oxia challenged neuronal CM decreased in vitro capillary
tube formation, it did not achieve statistical significance.
However, brain endothelial cells treated with hypoxia
challenged astrocytic CM significantly decreased the
brain endothelial angiogenic potential compared to hyp-
oxia challenged brain endothelial CM (Figure 2F).
OGDR Both OGDR challenged neuronal and astrocytic
CM significantly decreased brain endothelial in vitro ca-
pillary tube formation compared to OGDR challenged
brain endothelial CM (Figure 2G).
Brain endothelial, neurovascular and gliovascular
adhesive interactions with lymphocytes are modulated by
in vitro ischemic metabolic stresses
Effect of ischemic metabolic stresses on brain endothelial-
lymphocyte adhesion
While aglycemia did not affect brain endothelial-lymphocyte
adhesive interactions, hypoxia and OGDR challenged
brain endothelial cells significantly promoted lympho-
cyte adhesion in vitro compared to control (nomal)
(Figure 3A).
Effect of ischemic metabolic stresses on
neurovascular-lymphocyte adhesion
While aglycemia and hypoxia challenged neurovascula-
ture did not affect lymphocyte adhesive interactions,
OGDR challenged neurovasculature significantly pro-
moted lymphocyte adhesion in vitro compared to con-
trol (normal) (Figure 3B).
Effect of ischemic metabolic stresses on
gliovascular-lymphocyte adhesion
While aglycemia challenged gliovasculature did not
affect lymphocyte adhesive interactions, both hypoxiaand OGDR significantly increased lymphocyte adhesion
in vitro compared to control (normal) (Figure 3C).
Comparison between brain endothelial, neurovascular and
gliovascular-lymphocyte adhesive interactions
Normal Interestingly, both neuronal and astrocytic in-
teractions during normal conditions significantly pro-
moted lymphocyte interactions compared with normal
brain endothelial cells (Figure 3D).
Aglycemia While aglycemia challenged neurovascula-
ture did not significantly induce lymphocyte adhesion,
aglycemia challenged gliovasculature significantly in-
creased lymphocyte adhesion compared to aglycemia
challenged brain endothelial cells (Figure 3E).
Hypoxia While hypoxia challenged neurovasculature
significantly decreased lymphocyte adhesion, hypoxia
challenged gliovasculature did not affect lymphocyte ad-
hesion compared to hypoxia challenged brain endothe-
lial cells (Figure 3F).
OGDR Both OGDR challenged neurovasculature and
gliovasculature significantly promoted lymphocyte adhe-
sion compared to OGDR challenged brain endothelial
cells in vitro (Figure 3G).
Brain endothelial ECAM expression is modulated by
metabolically stressed neurons and astrocytes during
in vitro ischemic metabolic stresses
ICAM-1 CM from normal, aglycemia, hypoxia and
OGDR challenged neurons and astrocytes significantly
increased ICAM-1 expression on brain endothelial cells
(Figure 4A, Additional file 2: Figure S2A, Additional file 3:
Figure S3A).
VCAM-1 Neuronal or astrocytic normal CM did not in-
duce VCAM-1 expression compared to normal brain
endothelial CM. However, aglycemia, hypoxia and OGDR
challenged astrocytic CM significantly induced VCAM-1
expression compared to respective CM from brain endo-
thelial cells. No differences with CM from neurons in any
of these conditions significantly affected VCAM-1 expres-
sion compared to respective CM from brain endothelial
cells (Figure 4B, Additional file 2: Figure S2B, Additional
file 3: Figure S3A).
MAdCAM-1 None of the treatment conditions except CM
from aglycemia challenged neurons affected MAdCAM-1
expression in brain endothelia cells. CM from aglycemia
challenged neurons significantly decreased MAdCAM-1
expression compared to aglycemia challenged brain
Figure 3 Differential effects of metabolic stresses on brain endothelial, neurovascular and gliovascular-leukocyte adhesive interactions.
A. Effect of metabolic stresses on brain endothelial-lymphocyte adhesion. Hypoxic and OGDR treated brain endothelial cells significantly promoted
lymphocyte adhesion compared to untreated and aglycemic brain endothelial cells. B. Effect of metabolic stresses on neurovascular-lymphocyte
adhesion. Similar to brain endothelial-lymphocyte adhesion, hypoxia and OGDR significantly induced neurovascular-lymphocyte adhesion
compared to untreated and aglycemic neurovascular-lymphocyte adhesion. C. Effect of metabolic stresses on gliovascular-lymphocyte adhesion.
Similar to brain endothelial and neurovascular-lymphocyte adhesion, hypoxia and OGDR significantly induced gliovascular-lymphocyte adhesion
compared to untreated and aglycemic gliovascular-lymphocyte adhesion. D. Comparison of untreated brain endothelial, neurovascular and
gliovascular-lymphocyte adhesion. A significant increase in neurovascular and gliovascular-lymphocyte adhesion was observed compared to
untreated brain endothelial cells. E. Comparison of aglycemic brain endothelial, neurovascular and gliovascular-lymphocyte adhesion. A significant
increase in aglycemic neurovascular and gliovascular-lymphocyte adhesion was observed compared to aglycemic brain endothelial cells.
F. Comparison of hypoxic brain endothelial, neurovascular and gliovascular-lymphocyte adhesion. No significant difference in hypoxic neurovascular
and gliovascular-lymphocyte adhesion compared to hypoxic brain endothelial cells was observed. G. Comparison of OGDR brain endothelial,
neurovascular and gliovascular-lymphocyte adhesion. A significant increase in OGDR neurovascular and gliovascular-lymphocyte adhesion was
observed compared to OGDR brain endothelial cells. Un-paired t-test is used to check statistical significance between two groups. *P < 0.05
considered significantly different from controls.
Chaitanya et al. Cell Communication and Signaling 2014, 12:7 Page 7 of 14
http://www.biosignaling.com/content/12/1/7endothelial CM (Figure 4C, Additional file 2: Figure S2C,
Additional file 3: Figure S3B).
PECAM-1 CM from astrocytes from all treatment con-
ditions significantly induced PECAM-1 expression com-
pared to respective CM from brain endothelial cells. CM
for neurons did not show any significant differences
in PECAM-1 expression (Figure 4D, Additional file 2:
Figure S2D, Additional file 3: Figure S3B).
E-Selectin No significant difference in E-selectin ex-
pression was observed between CM from normal neu-
rons or astrocytes compared to CM from normal brain
endothelial cells. However, both aglycemia challenged
neurons and astrocytes significantly induced E-selectin
expression compared to aglycemia challenged brain
endothelial cells. Interestingly, while hypoxia or OGDRchallenged neurons did not show any difference in
MAdCAM-1 expression, hypoxia and OGDR challenged
astrocytes significantly induced MAdCAM-1 expression
compared to respective CM from brain endothelial cells
(Figure 4E, Additional file 2: Figure S2E, Additional file 3:
Figure S3A).
P-Selectin While CM media from normal astrocytes
significantly induced P-selectin expression, CM from
normal neurons did not induce significant P-selectin ex-
pression (p = 0.09). Neither aglycemia challenged CM
from neurons nor astrocytes affected P-selectin expres-
sion compared to respective CM from brain endothelial
cells. Furthermore, neither hypoxia nor OGDR chal-
lenged CM from neurons induced P-selectin expression
compared to respective CM from brain endothelial cells.
However, both hypoxia and OGDR challenged astrocytic
Figure 4 Differential brain ECAM expression by metabolically stressed brain endothelial, neuronal and astrocyte secreted factors.
A. Comparison of brain endothelial ICAM-1 expression. A significant increase in brain endothelial ICAM-1 expression was observed with CM obtained
from astrocytes and neurons from all conditions compared to respective brain endothelial CM. B. Comparison of brain endothelial VCAM-1
expression. While no significant increase in brain endothelial VCAM-1 expression was observed with any of neuronal CM, hypoxic and OGDR
astrocytic CM significantly increased brain endothelial VCAM-1 expression compared to respective brain endothelial CM. C. Comparison of brain
endothelial MAdCAM-1 expression. No significant difference in brain endothelial MAdCAM-1 expression was observed with CM obtained from
astrocytes and neurons from any of conditions compared to respective brain endothelial CM. D. Comparison of brain endothelial PECAM-1
expression. While no significant difference in brain endothelial MAdCAM-1 expression was observed with any of neuronal CM, astrocytic CM from
all conditions significantly increased brain endothelial PECAM-1 expression compared to respective brain endothelial CM. E. Comparison of brain
endothelial E-selectin expression. A significant increase in brain endothelial E-selectin was observed with both normal and aglycemic neuronal and
astrocytic CM compared to respective brain endothelial CM. However, while neither hypoxic nor OGDR neuronal CM increased brain E-selectin
expression, both hypoxic and OGDR astrocytic CM significantly increased E-selectin expression compared to respective brain endothelial CM.
F. Comparison of brain endothelial P-selectin expression. Except OGDR astrocytic CM, none of the other conditions significantly induced brain
endothelial P-selectin expression compared to respective brain endothelial CM. Un-paired t-test was used to check significance between 2
specific groups. *P < 0.05 considered significantly different from controls.
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CM from brain endothelial cells (Figure 4F, Additional
file 2: Figure S2F, Additional file 3: Figure S3B).
Discussion and conclusions
Pathology of cerebral ischemia involves a highly complex
association of inflammatory and immune events at the
neurovascular and gliovascular units [14,20,22,23,31,34,35].
The BBB, the crucial entity that shields neurovascular
and gliovascular units from the systemic challenges, is
highly compromised during ischemic insult [36-39]. Is-
chemic insult initiates an extensive chain of events at
these units both at biophysical and biochemical levels[7,8,38-43]. The signaling events and interactions be-
tween the cell types in these units during cerebral
ischemia are extremely difficult to elucidate. Hence, the
3D models of neurovascular and gliovascular interactions
provide a highly useful system to understand endothelial
responses in modulating the BBB permeability that affects
cerebral edema, post ischemic brain angiogenesis (asso-
ciated with the survival of stroke patients) and leukocyte
interactions that aggravate ischemia reperfused (I/R)
stroke brain damage [28,35,36,44].
While several previous reports have shown that in-
flammation and hypoxia leads to BBB breakdown [45], it
was not still clear whether glucose unavailability or
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tions are implicated in this process. In our brain endo-
thelial, gliovascular and neurovascular barrier studies, a
very interesting barrier regulation by neurons and astro-
cytes during the metabolic stresses of cerebral ischemia
was observed. While normal brain endothelial responses
to the metabolic stresses were only modest, gliovascular
and neurovascular barrier showed a dramatic increase in
barrier under OGDR conditions. Interestingly, while
hypoxic neurovascular and gliovascular barrier showed
either no effect or decreased barrier respectively, aglyce-
mic neurovascular and gliovascular barriers showed
modest increase in barrier as compared to OGDR. These
results clearly indicate that aglycemia might be the
underlying component in increased barrier suggesting
that OGDR can produce a highly adaptive and protective
barrier phenotype. These results indicate that during is-
chemic stress, neuronal and astrocytic responses might
synergize with OGDR to attenuate BBB permeability and
in the recovery of the barrier. However, these stresses
coupled with unrestricted levels of cytokines, chemo-
kines and proteases in the ischemic infarct might skew
the adaptive nature of BBB and lead to increased perme-
ability [46,47].
One of the main reasons in OGDR mediated barrier
increase can be explained in terms energy conservation.
During aglycemic cell stress, lack of glucose stimulates
endothelium to conserve their energy sources by shut-
ting down the cellular metabolic process and diverting
the cellular energy pools to maintain barrier integrity
and in endothelial reparative processes. This process is
observed during the cellular attempt to maintain an
adaptive phenotype to sustain throughout the cell stress
as long as possible and to prepare for an ordered apop-
totic cell death rather than necrosis [48]. Similar to our
previous observations, we expect that during aglycemic
conditions, the endothelium attempts to protect and
maintain barrier integrity as a primary event in the at-
tenuating brain edema during cerebral ischemia [24].
While aglycemia results in this protective phenotype,
availability of glucose in hypoxic stress might lead to sig-
naling events in an opposite direction. These results in-
dicate that availability of either oxygen or glucose alone
might play a pivotal role in determining endothelial
phenotype during cerebral ischemia. However, a combin-
ation of these mutual opposite barrier modulating events
resulted in a more beneficial barrier phenotype due to
the underlying signaling events initiated by aglycemic
stress. The molecular signaling events involved in OGDR
mediated improved barrier needs to be further investi-
gated. These responses were also observed in the in vitro
angiogenesis assay during these metabolic stresses.
In our in vitro angiogenesis experiments, a significant
impact of metabolically stressed astrocytic and neuronalsecreted factors on brain endothelial angiogenic poten-
tial was observed. While aglycemia, hypoxia and OGDR
significantly increased brain endothelial angiogenesis,
metabolic stressed neuronal CM did not show any effect
compared to control (normal neuronal CM). However,
aglycemic and OGDR astrocytic CM significantly in-
creased brain endothelial angiogenesis. A comparison
between different groups with the same treatment
showed that, while normal neuronal CM significantly in-
creased capillary tube formation, normal astrocyte CM
did not compared to normal brain endothelial CM.
Interestingly, both hypoxic and OGDR CM from astro-
cytes and neurons significantly decreased capillary tube
formation. Since increased angiogenesis is highly re-
quired for the reparative process, these results were puz-
zling. However, we expect that the factors secreted by
metabolically stressed neurons and astrocytes might be
responsible for this effect. It is also clear that while agly-
cemia plays a major role in modulating OGDR astrocytic
and neuronal barrier, hypoxia plays a prominent role in
modulating brain endothelial angiogenic potential by
OGDR astrocytes and neurons. The pathophysiological
role of neuronal and astrocytic physical interactions and
the secreted cell signaling mediators in mediating brain
endothelial angiogenic potential needs to be investigated.
Post ischemic brain angiogenesis has been strongly as-
sociated with stroke mortality and outcomes. While in-
creased post I/R brain angiogenesis is associated with
better outcome, decreased angiogenesis is associated
with increased mortality [28,49-51]. Neurovascular and
gliovascular interactions display an extremely complex
internal and external cross talk in CNS vascularization.
Recent reports have shown that both astrocytic and
neuronal tropic factors can not only modulate endothe-
lial pro-angiogenic activity directly but also by recruiting
hematopoietic precursors from the circulation [52,53].
However, the inherent mechanisms that control the is-
chemic brain angiogenesis at the neurovascular units
and the cellular mechanisms and associations that are
required for improved cerebral blood flow are not yet
known. One of the most important aspects in the angio-
genesis at the bioenergetics level is the conservation of
energy [54,55]. For example, during less severe ischemic
brain damage, angiogenesis can help to attempt increase
blood supply and results in the association with in-
creased survival. However, if the severity is too large, in-
duction of angiogenesis will only result in the depletion
of energy stores and in the aggravation of brain damage.
This is similar to the function of poly ADP ribose
polymerase-1 (PARP-1) which at sub injury level helps
in the repair of damaged DNA and the recovery of the
cell. However, during extensive cellular damage, PARP-1
utilizes the energy reserves and results in necrotic cell
death and increased tissue injury [56]. The role of
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cular units in governing post-stroke brain angiogenesis
and how their intimate association modulates immune re-
sponses during cerebral ischemia are not yet clear [57,58].
During cerebral ischemia, increased reactive oxygen
species, cytokines and microglial responses leads to a
highly inflamed endothelium which actively participates
in systemic leukocytes adhesion and infiltration into the
brain [59,60]. In the extensively damaged BBB of the
necrotic infarct core, leukocyte infiltration is ECAM in-
dependent [61,62]. However, in the relatively intact BBB
of the infarct penumbra, leukocyte infiltration proceeds
via ECAM dependent [61,62]. Increased expression of
ECAMs is one of the typical features of reactive brain
endothelium [62]. We have previously observed that
metabolic stresses of cerebral ischemia contribute differ-
entially to the expression profiles of brain ECAMs [25].
However, it is not clear how metabolically stressed neu-
rons and astrocytes contribute to this process. While as-
trocytes are inert to immune cell interactions, reactive
astrocyte secrete several proteases and cytokines that
modulate endothelial properties in driving leukocyte in-
teractions [44,63,64]. Furthermore, neurons were also
shown to support leukocyte adhesion and mediated
damage [44,46,63,65-69]. Hence, it becomes apparent
that several intercellular signaling mechanisms might
operate in the neurovascular and gliovascular units that
can potentially modulate brain endothelial responses to
leukocyte recruitment during cerebral ischemia.
In our brain endothelial, gliovascular and neurovascu-
lar lymphocyte adhesion assay, while hypoxic and OGDR
brain endothelium actively supports lymphocyte adhe-
sion, astrocyte CM or neuronal CM during any meta-
bolic stress did not affect brain endothelial lymphocyte
adhesion compared to normal CM. However, we ob-
served from a comparison between the groups with the
same treatment that both neurovascular and gliovascular
interactions show significant increase in the lymphocyte ad-
hesion correlating with increased brain endothelial ICAM-
1 expression with normal astrocytic or neuronal CM. Inter-
estingly, while aglycemia and hypoxic neuronal or astrocytic
CM did not show any significant difference from aglycemic
or hypoxic brain endothelium in lymphocyte adhesion,
OGDR CM from both astrocytes and neurons significantly
increased lymphocyte adhesion compared to OGDR brain
endothelium, clearly indicating that cerebral ischemia in-
duces neurovascular and gliovascular adhesive interactions
with lymphocytes.
One of the most interesting findings in our current
study was observed in ICAM-1 expression. A significant
increase in the basal expression of ICAM-1 was ob-
served when treated with astrocyte or neuronal CM as
compared to brain endothelial CM even under normal
conditions. This indicates that ICAM-1 might be aprincipal player in mediating physiological neurovascular
or gliovascular immune cell interactions. Since ICAM-1
was also used as an inflammatory endothelial marker
[70], the expression of ICAM-1 should exceed the neu-
rovascular or gliovascular ICAM-1 basal expression levels
to participate in pathophysiological leukocyte endothelial
interactions. While our data suggests that ICAM-1 might
be key player in leukocyte-neurovascular and gliovascu-
lar adhesive interactions under physiological conditions,
VCAM-1 and PECAM-1 which showed significant in-
creases during OGDR astrocyte CM might play a potential
role during pathophysiological conditions. Furthermore,
E-selectin which showed a prominent increase with
OGDR astrocyte CM might play an important role in initi-
ating neutrophil interactions to brain endothelium [71].
While several treatment combinations may be required to
further understand the roles of these ECAM modulation
by neurovascular and gliovascular units in initiation and
propagation of leukocyte interactions, our current study
provides a basic understanding on how metabolic stresses
can affect neuronal and astrocytic interactions in modulat-
ing brain endothelial interactions with lymphocytes.
Materials and methods
Cell culture
HBMEC3, a human brain endothelial cell line (provided
by Dr. Anat Erdreich-Epstein, Univ. of Southern Califor-
nia) was cultured in Roswell Park Memorial Institute
(RPMI) medium supplemented with 10% fetal calf serum
and 1% penicillin/streptomycin/Amphotericin. HFA, a
human astrocyte cell line (provided by Dr. Danica Stani-
mirovic, Univ. Ottawa), and SHSY-5Y, (HN) a human
neuronal cell line, were cultured in Dulbecco Modified
Eagles medium (DMEM) supplemented with 10% FCS
and 1% PSA [24,25].
Neurovascular and Gliovascular culture conditions
Neurovascular barrier was maintained by culturing
HBMEC3 in the upper chamber (insert) with 10% RPMI
and SHSY-5Y in the lower chamber with 10% DMEM.
Similarly, gliovascular barrier was maintained by cultur-
ing HBMEC3 in the upper chamber (insert) with 10%
RPMI and HFA in the lower chamber with 10% DMEM.
Neurovascular Barrier treatment conditions
HBMEC3 was cultured on the inside of the 8.0 μm insert
and SHSY-5Y on the other side (bottom side) of the insert.
This allows the formation of contact dependent neurovas-
cular barrier. Six hours after in vitro N, A, H or O simula-
tion, inserts with neurovascular barrier were incubated in
10% RPMI in the insert and 10% DMEM in the lower
chamber. The barrier was measured every 24 h. The time
point of addition of media after simulation was considered
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Gliovascular Barrier treatment conditions
HBMEC3 was cultured on the inside of the 8.0 μm in-
sert and HFA was cultured on the other side (bottom
side) of the insert. This allows the formation of contact
dependent gliovascular barrier. Six hours after in vitro
N, A, H or O simulation, inserts with gliovascular bar-
rier were incubated in 10% RPMI in the insert and 10%
DMEM in the lower chamber. The barrier was measured
every 24 h. The time point of addition of media after
simulation was considered 0 h and also the baseline for
all other time points in the group [24].
Brain endothelial barrier treatment conditions
After challenging with normal, aglycemia, hypoxia or
OGD for 6 h, cells were incubated in 10% RPMI in the
insert and 10% DMEM in the lower chamber under nor-
moxic conditions to match gliovascular and neurovascular
treatment conditions as described above. This treatment
condition allowed to compensate for media differences
among brain endothelial, gliovascular and neurovascular
barrier and to compare the barrier readings among
brain endothelial, gliovascular and neurovascular bar-
riers. The barrier was recorded with an EVOM meter
every 24 h as previously described [24]. The time point
of addition of media after simulation was considered
0 h and also the baseline for all other time points in
the group.
Human lymphocyte isolation
Lymphocytes were isolated from peripheral blood as pre-
viously described by ficoll-hypaque (1.077) method.
Lymphocytes were activated using PMA/calcium iono-
phore as previously described [46].
Carboxyfluorescein succinimidyl ester (CFSE) labeling
Lymphocytes were suspended in PBS with 5 mM CFSE
for 10 min with occasional mixing. After 10 min cells
were kept on ice and suspended in ice cold PBS. Later,
cells were washed 3 times and suspended in 10% RPMI
and incubated in the incubator under normal culture
conditions.
Brain endothelial-Lymphocyte adhesion
In order restrict any lymphocyte trans-endothelial mi-
gration across brain endothelial, gliovascular or neuro-
vascular barriers (cultured on 8.0 μm pore inserts), we
used 1.0 μm pore inserts in the lymphocyte adhesion as-
says. We expected that a pore size restriction (8.0 μm vs.
1.0 μm) might help restrict migration of lymphocytes
across these barriers and can produce a more accuratemeasurement of lymphocyte adhesion to the brain endo-
thelial, gliovascular and neurovascular barriers.
HBMEC3 was cultured inside of the 1.0 μM insert and
was subjected to N, A, H or O. After treatment, cells
were incubated in normal medium for 24 h. Later, CFSE
labeled, PMA/calcium ionophore activated (for 24 h) hu-
man lymphocytes were added to each insert and incu-
bated for 1 h in the incubator. Later, inserts were
washed 3 times with PBS and fluorescence of attached
lymphocytes was measured by a fluorescent plate reader
with fixed gain. To decrease deviation/error in these ex-
periments adhesion assays were performed at the same
time. Gain remained fixed in all adhesion assays.
Neurovascular-Lymphocyte adhesion
HBMEC3 was cultured on the inside of the 1.0 μm in-
sert and SHSY-5Y was cultured on the other side (bot-
tom side) of the insert. After in vitro N, A, H or O for
6 h inserts with neurovascular barrier were incubated in
10% RPMI in the insert and 10% DMEM in the lower
chamber. Later, CFSE labeled, PMA/calcium ionophore
activated (for 24 h) human lymphocytes were added to
each insert and incubated for 1 h in the incubator. Later,
inserts were washed 3 times with PBS and fluorescence
of attached lymphocytes was measured by a fluorescent
plate reader with fixed gain.
Gliovascular-Lymphocyte adhesion
HBMEC3 was cultured on the inside of the 8.0 μm in-
sert and HFA was cultured on the other side (bottom
side) of the insert. This allows the formation of contact
dependent gliovascular barrier. After in vitro N, A, H or
O for 6 h inserts with gliovascular barrier were incu-
bated in 10% RPMI in the insert and 10% DMEM in the
lower chamber. Later, CFSE labeled, PMA/calcium iono-
phore activated (for 24 h) human lymphocytes were
added to each insert and incubated for 1 h in incubator.
Later, inserts were washed 3 times with PBS and fluores-
cence of attached lymphocytes was measured by a fluor-
escent plate reader with fixed gain.
Conditioned media
HBMEC3, SHSY-5Y and HFA were subjected to N, A, H
or O for 6 h followed by incubating in normal culture
conditions. After 24 h, N, A, H or O conditioned media
from HBMEC3, SHSY-5Y or HFA were collected and fil-
tered through a 0.22 μm filter and stored at −80 °C until
use.
Western blot analysis
HBMEC3 cells were treated with conditioned media ob-
tained from HBMEC3 (N, A, H or O), HFA (N, A, H or
O) or SHSY-5Y (N, A, H or O) for 24 h. Later, cells were
collected in a non-reducing sample buffer with a
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tor and were resolved in an SDS-PAGE and immuno-
blotted with ICAM-1, VCAM-1, MAdCAM-1, PECAM-1,
E-Selectin and P-Selectin.
Antibodies
ICAM-1 (Cat. No. 09351D, 1:500) was purchased from
Pharmingen, San Diego, CA, USA; VCAM-1 (Cat. No.
553329, 1:500) was purchased from BD Biosciences, San
Diego, CA, USA; MAdCAM-1 (MECA-367, Cat. No.
09721D, 1:500) was purchased from BD Pharmingen,
San Diego, CA, USA; PECAM-1 (Cat. No. 550274,
1:500) was purchased from BD Pharmingen; E-selectin
(Cat. No. 553748, 1:500) was purchased from BD Biosci-
ences; P-selectin (Cat. No. 09480D, 1:1000) was pur-
chased from Pharmingen.
In vitro angiogenesis
HBMEC3 cells were treated with conditioned media ob-
tained from HBMEC3 (N, A, H or O), HFA (N, A, H or
O) or SHSY-5Y (N, A, H or O) for 24 h. Later, cells were
trypsinized and plated in matrigel for 3 h on 96-well
black walled plates. Capillary tube like structure forma-
tion on the matrigel was photographed at the concave
center of the well and the number of vessel like struc-
tures in each image was counted [72].
Statistics
Graphpad-3 InStat™ software was used to perform statis-
tical analyses. Repeated measures ANOVA was used for
barrier studies. One way ANOVA or repeated measures
ANOVA each with Dunnett's' post-hoc test or Bonfer-
roni post-test were used to determine statistical signifi-
cance. Sigmaplot™ was used to generate plots. *p < 0.05
was considered to be statistically significant, **p < 0.01
very significant, and ***p < 0.001 highly significant.
Additional files
Additional file 1: Figure S1. Differential effects of metabolic stresses
on brain endothelial, neurovascular and gliovascular barriers. A. Brain
endothelial barrier. HB3-N: Normal brain endothelial barrier, HB3-A:
Aglycemic brain endothelial barrier, HB3-H: Hypoxic brain endothelial
barrier, HB3-O: OGDR brain endothelial barrier. B. Neurovascular barrier.
HB3/HN-N: Normal neurovascular barrier, HB3/HN-A: Aglycemic neurovascular
barrier, HB3/HN-H: Hypoxic neurovascular barrier, HB3/HN-O: OGDR neurovas-
cular barrier. C. Gliovascular barrier. HB3/HFA-N: Normal gliovascular barrier,
HB3/HFA-A: Aglycemic gliovascular barrier, HB3/HFA-H: Hypoxic gliovascular
barrier, HB3/HFA-O: OGDR gliovascular barrier. D. Comparison of untreated
brain endothelial, neurovascular and gliovascular barriers. E. Comparison of
aglycemic brain endothelial, neurovascular and gliovascular barriers. F.
Comparison of hypoxic brain endothelial, neurovascular and gliovascular barriers.
G. Comparison of OGDR brain endothelial, neurovascular and gliovascular
barriers. Repeated measures ANOVA for repeated time course measurements
from 0 h baseline. Values are expresses in percent ± SEM. Un-paired t-test was
used to check significance between groups at the same time point. #P < 0.05
is considered significantly different from controls at the same time point.Additional file 2: Figure S2. Differential brain ECAM expression by
metabolically stressed brain endothelial, neuronal and astrocyte secreted
factors. A. ICAM-1. No significant difference in brain endothelial ICAM-1
expression was observed by any of brain endothelial, astrocytic or neuronal
CM compared to respective CM. B. VCAM-1. A significant increase in brain
endothelial VCAM-1 expression was observed by hypoxic and OGDR treated
brain endothelial CM (self-conditioned medium) compared to untreated
brain endothelial CM. None of the neuronal or astrocytic CM induced brain
endothelial VCAM-1 expression compared to respective untreated CM C.
MAdCAM-1. None of the CM induced brain endothelial MAdCAM-1
expression compared to respective untreated CM. D. PECAM-1. None of the
CM induced brain endothelial PECAM-1 expression compared to respective
untreated CM. E. E-selectin. None of the CM induced significant brain
endothelial E-selectin expression compared to respective untreated CM. F.
P-selectin. While none of the CM from brain endothelial cells or neurons
significantly induced P-selectin expression of brain endothelial cells, aglycemic,
hypoxic and OGDR astrocytic CM significantly induced brain endothelial
p-selectin expression compared to untreated astrocytic CM. Un-paired t-test
was used to check significance between 2 specific groups. *P < 0.05
considered significantly different from controls.
Additional file 3: Figure S3. Western blot images of brain ECAM
expression by metabolically stressed neurons and astrocytes. Panels A
and B were presented based on the sequence of cell lysates loading. A.
ICAM-1, VCAM-1, P-Selectin and Actin expression. Order of protein
loading sequence in panel A: Lysates obtained from brain endothelial cells
treated with metabolically stressed brain endothelial conditioned medium,
conditioned medium from metabolically stressed neurons and conditioned
medium from metabolically stressed astrocytes. Expression of brain
endothelial ICAM-1, VCAM-1 and P-Selectin was normalized to actin
(loading control). B. MAdCAM-1, PECAM-1, E-Selectin and Actin expression.
Order of protein loading sequence in panel B: Lysates obtained from brain
endothelial cells treated with metabolically stressed brain endothelial
conditioned medium, conditioned medium from metabolically stressed
astrocytes and conditioned medium from metabolically stressed neurons.
Expression of brain endothelial MAdCAM-1, PECAM-1 and E-Selectin was
normalized to actin (loading control).Abbreviations
ICAM-1: Intercellular adhesion molecule-1; VCAM-1: Vascular cell adhesion
molecule-1; PECAM-1: Platelet endothelial cell adhesion molecule-1; MAd-
CAM-1: Mucosal addressin cell adhesion molecule-1; ECAM: Endothelial cell
adhesion molecule; PARP-1: Poly-ADP ribose polymerase-1; N: Normoxia
normoglycemia; H: Hypoxia; A: Aglycemia; O (OGDR): Oxygen glucose
deprivation and reoxygenation; EVOM: Epithelial Volt-ohm meter;
CFSE: Carboxyfluorescein succinimidyl ester; CM: Conditioned medium.
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